Pluripotent stem cell researches reaching clinical applications

Regeneration of invariant natural killer T (iNKT) cells: application of iPSC technology for iNKT cell-targeted tumor immunotherapy

Invariant natural killer T (iNKT) cells are a subset of innate-like T cells restricted by a major histocompatibility complex (MHC) class I-like molecule, CD1d. iNKT cells express an invariant T cell receptor (...

Authors: Takahiro Aoki, Shinichiro Motohashi and Haruhiko Koseki

Citation: Inflammation and Regeneration 2023 43:27

Content type: Review Published on: 12 May 2023
- View Full Text
- View PDF
Cell therapy for Parkinson’s disease with induced pluripotent stem cells

Parkinson’s disease (PD) is the second most common neurodegenerative disease and a prime target of cell therapies. In fact, aborted fetal tissue has been used as donor material for such therapies since the 198...

Authors: Asuka Morizane

Citation: Inflammation and Regeneration 2023 43:16

Content type: Review Published on: 27 February 2023
- View Full Text
- View PDF